Bionime Corporation (TPE:4737)

Market Cap	4.15B +2.7%
Revenue (ttm)	1.91B -0.4%
Net Income	-120.35M
EPS	-1.80
Shares Out	67.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,379,706
Average Volume	351,157
Open	57.10
Previous Close	56.50
Day's Range	56.60 - 62.10
52-Week Range	43.14 - 73.90
Beta	0.25
RSI	72.78
Earnings Date	Mar 17, 2026

About Bionime

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offers blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the prov...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2003
• Employees: 500
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4737